Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedJan 10, 2026
DataAggregated Company Financials
Companies6
  • 7D4.2%
  • 3M9.9%
  • 1Y-8.7%
  • YTD4.2%

In the last week, the Life Sciences industry is up 4.2%, with Evotec up 14%. In the past year, the industry is down 8.7%. As for the next few years, earnings are expected to grow by 25% per annum.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 10 Jan 2026€20.2b€7.5b€143.5m40.5x140.6x2.7x
Mon, 08 Dec 2025€20.0b€7.5b€143.9m38.3x139.1x2.7x
Wed, 05 Nov 2025€19.4b€7.5b€147.4m38.4x131.4x2.6x
Fri, 03 Oct 2025€19.6b€7.4b€157.8m22.4x123.9x2.6x
Sun, 31 Aug 2025€18.5b€7.4b€157.8m23.5x117.1x2.5x
Tue, 29 Jul 2025€18.9b€7.4b€108.0m26x175x2.5x
Thu, 26 Jun 2025€20.5b€7.3b€114.9m28.8x178.3x2.8x
Sat, 24 May 2025€21.3b€7.3b€114.9m28.6x185.3x2.9x
Mon, 21 Apr 2025€19.6b€7.3b€112.4m25.9x174.2x2.7x
Wed, 19 Mar 2025€22.8b€7.1b€156.5m28.2x145.7x3.2x
Fri, 14 Feb 2025€23.6b€7.1b€169.8m24.3x138.8x3.3x
Sun, 12 Jan 2025€22.3b€7.1b€169.8m25.7x131.5x3.2x
Tue, 10 Dec 2024€21.7b€7.1b€170.5m26.5x127.2x3.1x
Thu, 07 Nov 2024€22.6b€7.1b€171.2m29.2x132.2x3.2x
Sat, 05 Oct 2024€23.0b€7.1b€177.5m30x129.7x3.2x
Mon, 02 Sep 2024€25.6b€7.1b€172.8m36x148.1x3.6x
Wed, 31 Jul 2024€25.4b€7.0b€237.1m36.4x107.2x3.6x
Fri, 28 Jun 2024€23.0b€7.0b€333.3m29.9x68.9x3.3x
Sun, 26 May 2024€25.5b€7.0b€333.3m31.5x76.6x3.7x
Tue, 23 Apr 2024€28.1b€7.0b€329.0m35.4x85.4x4x
Thu, 21 Mar 2024€34.6b€7.1b€384.5m39.2x89.9x4.9x
Sat, 17 Feb 2024€32.2b€7.3b€516.3m36.9x62.4x4.4x
Mon, 15 Jan 2024€30.7b€7.3b€507.1m35.5x60.5x4.2x
Wed, 13 Dec 2023€30.4b€7.3b€507.1m32.5x59.9x4.2x
Fri, 10 Nov 2023€26.9b€7.3b€498.8m31x53.9x3.7x
Sun, 08 Oct 2023€26.1b€6.6b€498.8m38.1x52.4x3.9x
Tue, 05 Sep 2023€31.0b€6.6b€498.1m45.4x62.2x4.7x
Thu, 03 Aug 2023€30.0b€6.6b€425.8m42.1x70.5x4.6x
Sat, 01 Jul 2023€26.9b€6.7b€487.3m37.5x55.2x4x
Mon, 29 May 2023€27.1b€6.7b€487.3m37.3x55.6x4x
Wed, 26 Apr 2023€27.6b€6.7b€483.0m37.6x57.1x4.1x
Fri, 24 Mar 2023€30.1b€6.7b€594.3m34.6x50.7x4.5x
Sun, 19 Feb 2023€32.2b€6.5b€447.4m40.3x71.9x5x
Tue, 17 Jan 2023€31.6b€6.5b€447.4m38.9x70.6x4.9x
Price to Earnings Ratio

70.6x


Total Market Cap: €31.6bTotal Earnings: €447.4mTotal Revenue: €6.5bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 103.7x202420252026
Current Industry PE
  • Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 141x which is higher than its 3-year average PE of 104x.
  • The 3-year average PS ratio of 3.6x is higher than the industry's current PS ratio of 2.7x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 32% per year over the last three years.
  • Meanwhile revenues for these companies have grown 5.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market2.60%
Healthcare4.25%
Life Sciences4.20%
Clinical Research and Equipment4.20%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EVT Evotec€6.2913.8%
+€135.5m
-25.3%PS1.5x
1SXP SCHOTT Pharma KGaA€15.424.8%
+€105.4m
-39.5%PE15.9x
FA0 PExA€0.01914.7%
+€310.3k
39.3%PS31.4x
991 Vitruvia Medical€1.1010.0%
+€231.1k
10.0%n/a

Latest News